| 0 |
TANNING |
1 |
0.0068 |
| 1 |
INCREASED DOSE ADMINISTERED |
2 |
0.0064 |
| 2 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
25 |
0.0041 |
| 3 |
BREAST DISORDER FEMALE |
1 |
0.0039 |
| 4 |
NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED |
1 |
0.0037 |
| 5 |
DUODENOGASTRIC REFLUX |
1 |
0.0036 |
| 6 |
PRODUCT INFORMATION CONTENT COMPLAINT |
1 |
0.0036 |
| 7 |
FOREIGN BODY IN THROAT |
9 |
0.0029 |
| 8 |
HEMIHYPOAESTHESIA |
1 |
0.0028 |
| 9 |
VAGINAL PROLAPSE |
1 |
0.0023 |
| 10 |
POST PROCEDURAL DIARRHOEA |
1 |
0.0020 |
| 11 |
ENDOMETRIAL THICKENING |
1 |
0.0018 |
| 12 |
OESOPHAGEAL IRRITATION |
1 |
0.0017 |
| 13 |
BLOOD IMMUNOGLOBULIN A DECREASED |
1 |
0.0015 |
| 14 |
TRYPTASE INCREASED |
1 |
0.0014 |
| 15 |
POST-TRAUMATIC NECK SYNDROME |
1 |
0.0012 |
| 16 |
BLOOD IRON ABNORMAL |
1 |
0.0010 |
| 17 |
BLOOD IMMUNOGLOBULIN M DECREASED |
1 |
0.0010 |
| 18 |
HAEMANGIOMA OF LIVER |
1 |
0.0010 |
| 19 |
GENITAL HYPOAESTHESIA |
1 |
0.0010 |
| 20 |
BLADDER DILATATION |
1 |
0.0009 |
| 21 |
MENOPAUSAL SYMPTOMS |
2 |
0.0009 |
| 22 |
RECTAL PROLAPSE |
1 |
0.0008 |
| 23 |
PRODUCT PRESCRIBING ISSUE |
18 |
0.0008 |
| 24 |
TONIC CLONIC MOVEMENTS |
1 |
0.0008 |
| 25 |
BLOOD PRESSURE SYSTOLIC DECREASED |
3 |
0.0007 |
| 26 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 27 |
CYSTITIS INTERSTITIAL |
1 |
0.0006 |
| 28 |
LAZINESS |
1 |
0.0006 |
| 29 |
VERTIGO POSITIONAL |
1 |
0.0006 |
| 30 |
HANGOVER |
2 |
0.0006 |
| 31 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 32 |
BLADDER SPASM |
1 |
0.0005 |
| 33 |
SLEEP TERROR |
2 |
0.0005 |
| 34 |
FAECES PALE |
1 |
0.0004 |
| 35 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 36 |
BRAIN FOG |
6 |
0.0004 |
| 37 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 38 |
YAWNING |
1 |
0.0004 |
| 39 |
SOMNOLENCE |
70 |
0.0003 |
| 40 |
THORACIC VERTEBRAL FRACTURE |
1 |
0.0003 |
| 41 |
HOT FLUSH |
24 |
0.0003 |
| 42 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 43 |
DEPRESSION SUICIDAL |
1 |
0.0003 |
| 44 |
SNORING |
1 |
0.0003 |
| 45 |
VERTIGO |
16 |
0.0003 |
| 46 |
CLAVICLE FRACTURE |
1 |
0.0003 |
| 47 |
CHOKING |
5 |
0.0003 |
| 48 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 49 |
HEPATIC PAIN |
1 |
0.0002 |
| 50 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 51 |
EAR DISORDER |
1 |
0.0002 |
| 52 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 53 |
SKIN ABRASION |
1 |
0.0002 |
| 54 |
PARAESTHESIA ORAL |
3 |
0.0002 |
| 55 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 56 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 57 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 58 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 59 |
HEPATIC ENZYME INCREASED |
13 |
0.0002 |
| 60 |
CATATONIA |
1 |
0.0002 |
| 61 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 62 |
CHOKING SENSATION |
1 |
0.0002 |
| 63 |
GENERALISED TONIC-CLONIC SEIZURE |
3 |
0.0002 |
| 64 |
IMPAIRED DRIVING ABILITY |
2 |
0.0002 |
| 65 |
HYPERVENTILATION |
1 |
0.0002 |
| 66 |
THINKING ABNORMAL |
3 |
0.0002 |
| 67 |
SWELLING OF EYELID |
1 |
0.0002 |
| 68 |
LIVER DISORDER |
7 |
0.0002 |
| 69 |
NIGHT SWEATS |
5 |
0.0002 |
| 70 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 71 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
7 |
0.0001 |
| 72 |
INCORRECT DOSE ADMINISTERED |
33 |
0.0001 |
| 73 |
FORMICATION |
1 |
0.0001 |
| 74 |
IMPAIRED WORK ABILITY |
3 |
0.0001 |
| 75 |
FEELING DRUNK |
1 |
0.0001 |
| 76 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 77 |
DISSOCIATION |
1 |
0.0001 |
| 78 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 79 |
CONCUSSION |
1 |
0.0001 |
| 80 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 81 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 82 |
BLOOD DISORDER |
1 |
0.0001 |
| 83 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 84 |
CARDIOVASCULAR DISORDER |
3 |
0.0001 |
| 85 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 86 |
DEPRESSED MOOD |
6 |
0.0001 |
| 87 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 88 |
HAEMARTHROSIS |
1 |
0.0001 |
| 89 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 90 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 91 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 92 |
DRY THROAT |
1 |
0.0001 |
| 93 |
ALANINE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 94 |
HEAD INJURY |
3 |
0.0001 |
| 95 |
RENAL PAIN |
1 |
0.0001 |
| 96 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 97 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 98 |
PRODUCT USE ISSUE |
16 |
0.0001 |
| 99 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 100 |
POLYNEUROPATHY |
1 |
0.0001 |
| 101 |
PRESYNCOPE |
2 |
0.0001 |
| 102 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 103 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 104 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 105 |
DIZZINESS |
39 |
0.0001 |
| 106 |
MYDRIASIS |
1 |
0.0001 |
| 107 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 108 |
PARAESTHESIA |
12 |
0.0001 |
| 109 |
BEDRIDDEN |
1 |
0.0001 |
| 110 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 111 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 112 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 113 |
DIVERTICULITIS |
2 |
0.0001 |
| 114 |
SKIN REACTION |
1 |
0.0001 |
| 115 |
LETHARGY |
4 |
0.0001 |
| 116 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 117 |
APATHY |
1 |
0.0001 |
| 118 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 119 |
FATIGUE |
49 |
0.0001 |
| 120 |
MIGRAINE |
6 |
0.0001 |
| 121 |
LOSS OF CONSCIOUSNESS |
8 |
0.0001 |
| 122 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 123 |
SEIZURE |
7 |
0.0001 |
| 124 |
SYNCOPE |
6 |
0.0001 |
| 125 |
PALPITATIONS |
7 |
0.0001 |
| 126 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2 |
0.0001 |
| 127 |
DISTURBANCE IN ATTENTION |
3 |
0.0001 |
| 128 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 129 |
PANIC ATTACK |
2 |
0.0001 |
| 130 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 131 |
ABDOMINAL DISCOMFORT |
9 |
0.0001 |
| 132 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 133 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 134 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 135 |
HEADACHE |
31 |
0.0000 |
| 136 |
DRY MOUTH |
4 |
0.0000 |
| 137 |
RIB FRACTURE |
1 |
0.0000 |
| 138 |
ILLNESS |
5 |
0.0000 |
| 139 |
MOUTH ULCERATION |
1 |
0.0000 |
| 140 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 141 |
RETCHING |
1 |
0.0000 |
| 142 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 143 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 144 |
INTENTIONAL PRODUCT USE ISSUE |
4 |
0.0000 |
| 145 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 146 |
HEPATOTOXICITY |
1 |
0.0000 |
| 147 |
CHROMATURIA |
1 |
0.0000 |
| 148 |
TINNITUS |
2 |
0.0000 |
| 149 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 150 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 151 |
FEELING ABNORMAL |
10 |
0.0000 |
| 152 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 153 |
LIVER INJURY |
1 |
0.0000 |
| 154 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 155 |
FLUID RETENTION |
2 |
0.0000 |
| 156 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 157 |
SKIN ULCER |
1 |
0.0000 |
| 158 |
MUSCLE SPASMS |
7 |
0.0000 |
| 159 |
GASTRITIS |
1 |
0.0000 |
| 160 |
MOOD ALTERED |
1 |
0.0000 |
| 161 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 162 |
FLATULENCE |
2 |
0.0000 |
| 163 |
HYPERSOMNIA |
1 |
0.0000 |
| 164 |
ABDOMINAL PAIN |
8 |
0.0000 |
| 165 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 166 |
ABDOMINAL PAIN UPPER |
7 |
0.0000 |
| 167 |
INSOMNIA |
9 |
0.0000 |
| 168 |
APHASIA |
1 |
0.0000 |
| 169 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 170 |
DISCOMFORT |
2 |
0.0000 |
| 171 |
SUICIDAL IDEATION |
3 |
0.0000 |
| 172 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 173 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 174 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 175 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 176 |
HYPERHIDROSIS |
4 |
0.0000 |
| 177 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 178 |
NAUSEA |
24 |
0.0000 |
| 179 |
FUNGAL INFECTION |
1 |
0.0000 |
| 180 |
RASH MACULAR |
1 |
0.0000 |
| 181 |
PRODUCT USE IN UNAPPROVED INDICATION |
7 |
0.0000 |
| 182 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
| 183 |
DRUG INEFFECTIVE |
36 |
0.0000 |
| 184 |
DYSARTHRIA |
1 |
0.0000 |
| 185 |
HALLUCINATION |
2 |
0.0000 |
| 186 |
RASH |
11 |
0.0000 |
| 187 |
JOINT SWELLING |
3 |
0.0000 |
| 188 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 189 |
DYSKINESIA |
1 |
0.0000 |
| 190 |
TREMOR |
4 |
0.0000 |
| 191 |
POLLAKIURIA |
1 |
0.0000 |
| 192 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 193 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 194 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 195 |
VISION BLURRED |
3 |
0.0000 |
| 196 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 197 |
ADVERSE EVENT |
2 |
0.0000 |
| 198 |
HYPOKALAEMIA |
1 |
0.0000 |
| 199 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 200 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 201 |
DYSPHAGIA |
2 |
0.0000 |
| 202 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 203 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 204 |
PRURITUS |
8 |
0.0000 |
| 205 |
DYSPEPSIA |
2 |
0.0000 |
| 206 |
HYPOAESTHESIA |
3 |
0.0000 |
| 207 |
DRY EYE |
1 |
0.0000 |
| 208 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 209 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 210 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 211 |
NERVOUSNESS |
1 |
0.0000 |
| 212 |
ECZEMA |
1 |
0.0000 |
| 213 |
SPEECH DISORDER |
1 |
0.0000 |
| 214 |
BRADYCARDIA |
1 |
0.0000 |
| 215 |
DIARRHOEA |
12 |
0.0000 |
| 216 |
BLISTER |
1 |
0.0000 |
| 217 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 218 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 219 |
DECREASED APPETITE |
4 |
0.0000 |
| 220 |
BACK PAIN |
4 |
0.0000 |
| 221 |
BONE PAIN |
1 |
0.0000 |
| 222 |
IRRITABILITY |
1 |
0.0000 |
| 223 |
FEELING HOT |
1 |
0.0000 |
| 224 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 225 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 226 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 227 |
DEHYDRATION |
2 |
0.0000 |
| 228 |
ARTHRALGIA |
6 |
0.0000 |
| 229 |
INJURY |
1 |
0.0000 |
| 230 |
SLEEP DISORDER |
1 |
0.0000 |
| 231 |
ANXIETY |
4 |
0.0000 |
| 232 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 233 |
AGITATION |
1 |
0.0000 |
| 234 |
EPISTAXIS |
1 |
0.0000 |
| 235 |
PAIN |
8 |
0.0000 |
| 236 |
VOMITING |
6 |
0.0000 |
| 237 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 238 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 239 |
FALL |
4 |
0.0000 |
| 240 |
URTICARIA |
2 |
0.0000 |
| 241 |
BALANCE DISORDER |
1 |
0.0000 |
| 242 |
TACHYCARDIA |
1 |
0.0000 |
| 243 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 244 |
SWELLING |
1 |
0.0000 |
| 245 |
DYSPNOEA |
6 |
0.0000 |
| 246 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 247 |
ERYTHEMA |
2 |
0.0000 |
| 248 |
HAEMORRHAGE |
1 |
0.0000 |
| 249 |
MALAISE |
4 |
0.0000 |
| 250 |
WEIGHT INCREASED |
2 |
0.0000 |
| 251 |
DEPRESSION |
2 |
0.0000 |
| 252 |
RENAL FAILURE |
1 |
0.0000 |
| 253 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 254 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 255 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 256 |
DRUG INTERACTION |
1 |
0.0000 |
| 257 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 258 |
ALOPECIA |
1 |
0.0000 |
| 259 |
HYPOTENSION |
1 |
0.0000 |
| 260 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 261 |
HYPERTENSION |
1 |
0.0000 |
| 262 |
CONSTIPATION |
1 |
0.0000 |
| 263 |
OFF LABEL USE |
4 |
0.0000 |
| 264 |
WEIGHT DECREASED |
1 |
0.0000 |
| 265 |
COUGH |
1 |
0.0000 |
| 266 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 267 |
ASTHENIA |
1 |
0.0000 |